Ritika Sengupta

About

I am a Postdoctoral Research Fellow at the Bernhard Nocht Institute for Tropical Medicine, Hamburg, focusing on the immunopathology of Lassa fever patients. With over seven years of research experience in translational immunology, my work centres on applying insights from clinical and laboratory studies to improve patient care.

Previously, I served as Research Scientist II at the Tata Translational Cancer Research Centre, where I coordinated and analysed a multicentre clinical trial on pediatric acute lymphoblastic leukemia across six cancer centres in India. In an earlier role as Research Scientist I at the Inst. of Post Graduate Medical Education & Research (IPGMER), I contributed to the development and standardisation of diagnostic test systems for visceral leishmaniasis and post–kala azar dermal leishmaniasis.

I completed my PhD on the immunopathology of human leishmaniasis, studying immune dysregulation and its role in hypopigmentation, disease pathophysiology, and host–pathogen interactions.

Employment

• Bernhard Nocht Institute for Tropical Medicine Postdoctoral Research Fellow
  2025 - Present
• Tata Medical Center Research Scientist II
  2024 - 2025
• Institute of Post Graduate Medical Education and Research Research Scientist I
  2022 - 2024
• Institute of Post Graduate Medical Education And Research PhD. Research Scholar
  2016 - 2022

Education

• University of Calcutta Doctor of Philosophy (PhD)
  2016 - 2023
• University of Calcutta Masters in Science (MSc)
  2013 - 2015
• Lady Brabourne College Bachelors in Science (BSc)
  2010 - 2013

Projects & Funding

Projects & funding information is unavailable.

Publications (13)

• Mapping the immune landscape in South Asian post kala-azar dermal leishmaniasis
  Annals of Medical Science & Research 2025 DOI: 10.4103/amsr.amsr_48_24
  +Save
• IL-32-producing CD8+ memory T cells define immunoregulatory niches in human cutaneous leishmaniasis.
  The Journal of clinical investigation 2025 DOI: 10.1172/jci182040
  +Save
• Role of neutrophils in the pathogenesis of Post Kala-azar Dermal Leishmaniasis (PKDL).
  PLoS neglected tropical diseases 2024 DOI: 10.1371/journal.pntd.0012655
  +Save
• Immune dysregulation and inflammation causing hypopigmentation in post kala-azar dermal leishmaniasis: partners in crime?
  Trends in Parasitology 2023 DOI: 10.1016/j.pt.2023.07.005
  +Save
• Does immune dysregulation contribute towards development of hypopigmentation in Indian post kala-azar dermal leishmaniasis?
  Experimental dermatology 2023 DOI: 10.1111/exd.14760
  +Save
• Attenuation of methotrexate induced hepatotoxicity by epigallocatechin 3-gallate.
  Drug and chemical toxicology 2022 DOI: 10.1080/01480545.2022.2085738
  +Save
• Liposomal amphotericin B is more effective in polymorphic lesions of post kala-azar dermal leishmaniasis.
  Indian journal of dermatology, venereology and leprology 2022 DOI: 10.25259/ijdvl_338_20
  +Save
• Immune Responses in Post Kala-azar Dermal Leishmaniasis.
  Indian journal of dermatology 2020 DOI: 10.4103/ijd.ijd_258_20
  +Save
• Iron trafficking in patients with Indian Post kala-azar dermal leishmaniasis.
  PLoS neglected tropical diseases 2020 DOI: 10.1371/journal.pntd.0007991
  +Save
• Identification of atypical dermal leishmaniasis resolved by restriction fragment length polymorphism.
  Indian journal of dermatology, venereology and leprology 2020 DOI: 10.4103/ijdvl.ijdvl_14_18
  +Save